- Home
- GNFT vs CIA Comparison
GNFT vs CIA Comparison
Compare GNFT & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- CIA
- Stock Information
- Founded
- GNFT 1999
- CIA 1969
- Country
- GNFT France
- CIA United States
- Employees
- GNFT N/A
- CIA N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- CIA Life Insurance
- Sector
- GNFT Health Care
- CIA Finance
- Exchange
- GNFT Nasdaq
- CIA Nasdaq
- Market Cap
- GNFT 214.5M
- CIA 212.6M
- IPO Year
- GNFT 2019
- CIA N/A
- Fundamental
- Price
- GNFT N/A
- CIA $3.59
- Analyst Decision
- GNFT Strong Buy
- CIA
- Analyst Count
- GNFT 1
- CIA 0
- Target Price
- GNFT $13.00
- CIA N/A
- AVG Volume (30 Days)
- GNFT 4.2K
- CIA 489.8K
- Earning Date
- GNFT 04-24-2025
- CIA 08-05-2025
- Dividend Yield
- GNFT N/A
- CIA N/A
- EPS Growth
- GNFT N/A
- CIA N/A
- EPS
- GNFT 0.03
- CIA 0.17
- Revenue
- GNFT $73,187,701.00
- CIA $242,941,000.00
- Revenue This Year
- GNFT $15.98
- CIA $3.89
- Revenue Next Year
- GNFT N/A
- CIA $6.08
- P/E Ratio
- GNFT $125.30
- CIA $21.13
- Revenue Growth
- GNFT 105.01
- CIA 0.19
- 52 Week Low
- GNFT $2.55
- CIA $2.33
- 52 Week High
- GNFT $6.42
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- GNFT 47.81
- CIA 48.48
- Support Level
- GNFT $3.61
- CIA $3.45
- Resistance Level
- GNFT $3.95
- CIA $3.74
- Average True Range (ATR)
- GNFT 0.14
- CIA 0.21
- MACD
- GNFT -0.01
- CIA 0.03
- Stochastic Oscillator
- GNFT 57.01
- CIA 62.22
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.